The National Health Regulatory Authority (NHRA) today announced it has officially approved the registration of Sinopharm’s Covid-19 vaccine after the submission of all related documentation by G42 Healthcare, the company’s exclusive distributor in the Middle East and North Africa.
The NHRA’s decision to approve and use the vaccine is based on the clinical trials data conducted across several countries, which was thoroughly reviewed and evaluated by the Authority .
&uuid=(email))